LET'S ADVANCE REGENERATIVE MEDICINE TOGETHER
Interested in our science, therapeutic programs, or opportunities to collaborate? We would be pleased to hear from you.
Questions About Our Science & Approach
What is Corcellys Therapeutics developing?
Corcellys Therapeutics is developing regenerative cell therapies for severe ocular diseases. Our lead program focuses on limbal stem cell deficiency (LSCD), a condition in which loss or dysfunction of limbal stem cells prevents normal regeneration of the corneal surface.
What is limbal stem cell deficiency?
Limbal stem cells continuously renew the corneal epithelium and help maintain a clear and healthy ocular surface. When these cells are lost or severely impaired, the cornea can become unstable and vascularized, resulting in chronic discomfort, impaired vision and, in severe cases, blindness.
How is the Corcellys approach different?
Our approach brings together stem cell biology, scalable manufacturing, cryopreservation and translational development. We are developing a robust, cryopreserved cell therapy intended to support practical clinical use and regeneration of a functional corneal surface.
Who could potentially benefit from this therapy?
Our lead program is being developed for patients with severe limbal stem cell deficiency. This includes patients for whom existing treatment options are limited, particularly when sufficient healthy limbal tissue is not available for an autologous treatment approach.
What stage of development is the program at?
Our lead program is in preclinical development. We are advancing the therapy through further product development and translational studies designed to support its progression toward future clinical evaluation.
Is Corcellys working only on the cornea?
The cornea is our initial focus, where our team has extensive experience in stem cell biology and translational development. Over time, we see opportunities to apply our expertise and regenerative medicine platform to additional serious ocular diseases.
What is Corcellys Therapeutics’ Privacy Policy?
Corcellys Therapeutics respects your privacy and processes personal information only when necessary for legitimate business purposes. If you contact us through this website, we may collect information you voluntarily provide, such as your name, email address, organization and message, for the purpose of responding to your inquiry and maintaining relevant business correspondence.
We do not sell personal information or use information submitted through our contact form for unrelated marketing purposes. Personal data is handled in accordance with applicable data protection legislation, including the EU General Data Protection Regulation (GDPR), and retained only for as long as reasonably necessary for the purpose for which it was collected or as required by law.
If you have questions regarding your personal data or wish to request access, correction or deletion, please contact Corcellys Therapeutics using the contact details provided on this website.
What are the Terms of Use for this website?
The content of this website is provided by Corcellys Therapeutics for general scientific, corporate and informational purposes only. While we aim to keep the information accurate and current, no guarantee is made regarding its completeness, accuracy or continued availability.
Information concerning research programs, technologies or potential therapeutic applications may describe investigational activities that remain under development and may change as research progresses. Nothing on this website constitutes medical advice, an offer to provide medical treatment, or a representation that any investigational therapy will ultimately receive regulatory approval or become commercially available.
Unless otherwise indicated, the content, text, graphics and other materials on this website are owned by or used with permission by Corcellys Therapeutics and may not be reproduced or used for commercial purposes without prior permission.